Grisotti Flap as Oncoplastic Surgery for Retroareolar Breast Cancer

Introduction: The Grisotti procedure involves removing the central breast tumor involving nipple areolar complex and mobilizing a dermo-glandular flap that has been de-epithelized to generate an areola and restore the breast. The goal was to evaluate the technique's impact on oncological outcomes, postoperative side effects, patient and surgeon satisfaction levels. Patients and methods: From February 2023 to July 2024, twenty patients with a central breast cancer have been treated using the Grisotti technique. Results: The median of age of the patients was 58 years (41:75 years). The mean BMI was 30.07 kg/ m² (23.5:34.5 kg/m2). 45% of cases (9 patients) were diagnosed for hypertension and 30% of the cases (6 patients) were treated for Diabetes mellitus. Neoadjuvant chemotherapy was administered to six patients (30%), and three of them showed a partial response. Three cases (15%) had Paget's disease of the nipple, while the bulk of patients (85%, n = 17) had invasive ductal carcinomas (IDC). Fourteen patients (70%) reported excellent 6-month subjective patient satisfaction, whereas six patients (30%) reported good satisfaction. Conclusion: The Grisotti approach is a straightforward process that may be repeated with little difficulty. It enables the reconstruction of a new areola, the repair of the central glandular defect, and a carcinologically satisfactory central lumpectomy.